• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绵羊模型中采血部位和药物理化特性对鼻腔给药后生物利用度的影响。

The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability after nasal administration in the sheep model.

作者信息

Illum L, Hinchcliffe M, Davis S S

机构信息

West Pharmaceutical Services, Drug Delivery and Clinical Research Centre Ltd., Albert Einstein Centre, Nottingham Science and Technology Park, Nottingham NG7 2TN, United Kingdom.

出版信息

Pharm Res. 2003 Sep;20(9):1474-84. doi: 10.1023/a:1025722614154.

DOI:10.1023/a:1025722614154
PMID:14567644
Abstract

PURPOSE

Investigate the effect of blood sampling site and physicochemical characteristics of drugs on the pharmacokinetic (PK) parameters obtained after intravenous and nasal administration in sheep and compare results with computer simulations.

METHODS

Three drugs, insulin, morphine, and nicotine, were administered nasally and by intravenous (IV) injection to sheep, and serial blood samples collected concurrently from the carotid artery (insulin, morphine) or cephalic vein (nicotine) and jugular vein. Plasma drug concentrations were measured, and pharmacokinetic and statistical analyses performed, to evaluate sampling site differences.

RESULTS

After nasal insulin, bioavailabilities calculated from the two blood sampling site data were comparable. In contrast, apparent bioavailabilities following nasal morphine or nicotine were significantly higher when sampling was from the jugular vein. These results were supported by computer simulations. These observations are attributed to the greater effects of noninstantaneous mixing of drugs for jugular vein sampling following nasal dosing, compared to the other sampling sites, which is significant for drugs that are rapidly and well absorbed and that have a high volume of distribution (Vd).

CONCLUSION

The results clearly show that the characteristics of the drug and the blood sampling site can have a significant effect on the pharmacokinetic results obtained after nasal administration in sheep.

摘要

目的

研究采血部位和药物理化特性对绵羊静脉注射和鼻腔给药后获得的药代动力学(PK)参数的影响,并将结果与计算机模拟结果进行比较。

方法

将胰岛素、吗啡和尼古丁三种药物经鼻腔和静脉注射给予绵羊,并同时从颈动脉(胰岛素、吗啡)或头静脉(尼古丁)和颈静脉采集系列血样。测定血浆药物浓度,并进行药代动力学和统计分析,以评估采血部位差异。

结果

鼻腔给予胰岛素后,根据两个采血部位数据计算的生物利用度相当。相比之下,鼻腔给予吗啡或尼古丁后,从颈静脉采血时的表观生物利用度显著更高。这些结果得到了计算机模拟的支持。这些观察结果归因于鼻腔给药后颈静脉采血时药物非瞬时混合的影响比其他采血部位更大,这对于吸收迅速且良好且分布容积(Vd)高的药物具有重要意义。

结论

结果清楚地表明,药物特性和采血部位可对绵羊鼻腔给药后获得的药代动力学结果产生显著影响。

相似文献

1
The effect of blood sampling site and physicochemical characteristics of drugs on bioavailability after nasal administration in the sheep model.绵羊模型中采血部位和药物理化特性对鼻腔给药后生物利用度的影响。
Pharm Res. 2003 Sep;20(9):1474-84. doi: 10.1023/a:1025722614154.
2
The impact of the site of blood sampling on pharmacokinetic parameters following sublingual dosing to dogs.舌下给药后采血部位对犬药代动力学参数的影响。
J Pharmacol Toxicol Methods. 2013 Jan-Feb;67(1):1-4. doi: 10.1016/j.vascn.2012.10.004. Epub 2012 Nov 5.
3
Absolute bioavailability of nicotine applied to different nasal regions.尼古丁应用于不同鼻腔区域的绝对生物利用度。
Eur J Clin Pharmacol. 1991;41(6):585-8. doi: 10.1007/BF00314989.
4
One should avoid retro-orbital pharmacokinetic sample collections for intranasal dosing in rats: Illustration of spurious pharmacokinetics generated for anti-migraine drugs zolmitriptan and eletriptan.在大鼠进行经鼻给药时,应避免眶后部位的药代动力学采样:抗偏头痛药物佐米曲普坦和依来曲普坦产生假药代动力学的实例。
Eur J Pharm Sci. 2017 Aug 30;106:87-93. doi: 10.1016/j.ejps.2017.05.044. Epub 2017 May 23.
5
Utility of capillary microsampling for rat pharmacokinetic studies: Comparison of tail-vein bleed to jugular vein cannula sampling.毛细管微量采样在大鼠药代动力学研究中的应用:尾静脉采血与颈静脉插管采血的比较。
J Pharmacol Toxicol Methods. 2015 Nov-Dec;76:7-14. doi: 10.1016/j.vascn.2015.07.001. Epub 2015 Jul 9.
6
Intranasal delivery of morphine.
J Pharmacol Exp Ther. 2002 Apr;301(1):391-400. doi: 10.1124/jpet.301.1.391.
7
Nasal administration of morphine-6-glucuronide in sheep--a pharmacokinetic study.绵羊经鼻给予吗啡-6-葡萄糖醛酸苷——一项药代动力学研究。
Biopharm Drug Dispos. 1996 Nov;17(8):717-24. doi: 10.1002/(SICI)1099-081X(199611)17:8<717::AID-BDD985>3.0.CO;2-I.
8
In vivo evaluation of nicotine lyophilised nasal insert in sheep.尼古丁冻干鼻用插入剂在绵羊体内的评价
Int J Pharm. 2005 Nov 4;304(1-2):72-82. doi: 10.1016/j.ijpharm.2005.07.025. Epub 2005 Sep 23.
9
Impact of the blood sampling site on time-concentration drug profiles following intravenous or buccal drug administration.采血部位对静脉或口腔给药后药物浓度-时间曲线的影响。
J Vet Pharmacol Ther. 2014 Apr;37(2):145-50. doi: 10.1111/jvp.12075.
10
New model for intravenous drug administration and blood sampling in the awake rat, designed to increase quality and throughput for in vivo pharmacokinetic analysis.用于清醒大鼠静脉给药和采血的新模型,旨在提高体内药代动力学分析的质量和通量。
J Pharmacol Toxicol Methods. 2005 Sep-Oct;52(2):293-301. doi: 10.1016/j.vascn.2004.11.002. Epub 2004 Dec 29.

引用本文的文献

1
Fundamentals of Pharmacokinetics to Assess the Correlation Between Plasma Drug Concentrations and Different Blood Sampling Methods.评估血浆药物浓度与不同采血方法之间相关性的药代动力学基础。
Pharm Res. 2019 Jan 2;36(2):32. doi: 10.1007/s11095-018-2550-y.

本文引用的文献

1
Nasal drug delivery--possibilities, problems and solutions.鼻腔给药——可能性、问题与解决方案。
J Control Release. 2003 Feb 21;87(1-3):187-98. doi: 10.1016/s0168-3659(02)00363-2.
2
Nasal delivery of insulin using novel chitosan based formulations: a comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles.使用新型壳聚糖基制剂经鼻递送胰岛素:简单壳聚糖制剂与壳聚糖纳米颗粒在两种动物模型中的比较研究
Pharm Res. 2002 Jul;19(7):998-1008. doi: 10.1023/a:1016418523014.
3
Intranasal delivery of morphine.
J Pharmacol Exp Ther. 2002 Apr;301(1):391-400. doi: 10.1124/jpet.301.1.391.
4
Development of a novel nasal nicotine formulation comprising an optimal pulsatile and sustained plasma nicotine profile for smoking cessation.
J Control Release. 2002 Feb 19;79(1-3):243-54. doi: 10.1016/s0168-3659(01)00553-3.
5
Clearance characteristics of chitosan based formulations in the sheep nasal cavity.基于壳聚糖的制剂在绵羊鼻腔中的清除特性。
Int J Pharm. 2001 Apr 17;217(1-2):183-91. doi: 10.1016/s0378-5173(01)00602-0.
6
Intranasal absorption of buprenorphine--in vivo bioavailability study in sheep.丁丙诺啡的鼻腔吸收——绵羊体内生物利用度研究
Int J Pharm. 2000 Sep 15;205(1-2):159-63. doi: 10.1016/s0378-5173(00)00499-3.
7
Evaluation of the clearance characteristics of bioadhesive systems in humans.生物黏附系统在人体中的清除特性评估。
Int J Pharm. 1999 Feb 1;178(1):55-65. doi: 10.1016/s0378-5173(98)00367-6.
8
Nasal administration of morphine-6-glucuronide in sheep--a pharmacokinetic study.绵羊经鼻给予吗啡-6-葡萄糖醛酸苷——一项药代动力学研究。
Biopharm Drug Dispos. 1996 Nov;17(8):717-24. doi: 10.1002/(SICI)1099-081X(199611)17:8<717::AID-BDD985>3.0.CO;2-I.
9
Nasal delivery. The use of animal models to predict performance in man.鼻腔给药。使用动物模型预测人体中的效果。
J Drug Target. 1996;3(6):427-42. doi: 10.3109/10611869609015963.
10
Prediction of the volume of distribution from in vitro data and use for estimating the absolute extent of absorption.根据体外数据预测分布容积并用于估计吸收的绝对程度。
Int J Clin Pharmacol Ther Toxicol. 1980 Jul;18(7):298-316.